Yıl: 2022 Cilt: 32 Sayı: 3 Sayfa Aralığı: 351 - 356 Metin Dili: İngilizce DOI: 10.4274/terh.galenos.2022.53254 İndeks Tarihi: 08-05-2023

Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey

Öz:
Objective: The current study determines the causes of mortality in cases of human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) in a developing country where there is no difficulty in accessing antiretroviral therapy and to determine the measures that can be taken to reduce mortality. Methods: The study was conducted between 2003 and 2018. Patient data were extracted from patient files until 2007 and, after that date, from patient files and hospital information software. The cause of mortality was determined based on the patients’ complaints at admission, clinical, radiological, microbiological, and pathological findings. The causes of mortality were studied in three groups as “HIV-related”, “HIV-associated” and “other.” Results: The study enrolled 31 (10.8%) cases resulting in mortality from 287 patients followed up in our outpatient clinic. The average age of the cases was 47 (25-68) years and 27 (90%) of them were men. The cause of death of most of our patients was opportunistic infections, notably disseminated tuberculosis. Among the malignancies, AIDS-defining ones such as lymphoma and Kaposi's sarcoma were identified as the most common causes of death. Conclusion: Deaths were most frequently caused by “HIV-related” causes such as AIDS-related opportunistic infection and AIDS-defining malignancies. For an early diagnosis of HIV/AIDS, more efforts should be made to screen risk groups and keep diagnosed patients in follow-up and treatment.
Anahtar Kelime:

HIV Pozitif Kişilerde Mortalite Nedenleri: Türkiye’den 31 Olgunun Değerlendirilmesi

Öz:
Amaç: Çalışmamızın amacı, antiretroviral tedaviye erişimde zorluk yaşanmayan gelişmekte olan bir ülkede insan immün yetmezlik virüsü/edinilmiş immün yetmezlik sendromu (HIV/AIDS) olgularında ölüm nedenlerini belirlemek ve mortaliteyi azaltmak için alınabilecek önlemleri belirlemektir. Yöntem: Çalışma 2003-2018 yılları arasında gerçekleştirilmiştir. Hasta verileri 2007 yılına kadar hasta dosyalarından ve bu tarihten sonra hasta dosyalarından ve hastane bilgi yazılım sisteminden alınmıştır. Mortalite nedeni, hastaların başvuru şikayetleri, klinik, radyolojik, mikrobiyolojik ve patolojik bulgulara göre belirlenmiştir. Ölüm nedenleri “HIV ile ilişkili”, “HIV ile ilişkili” ve “diğer” olmak üzere üç grupta incelenmiştir. Bulgular: Çalışmaya polikliniğimizde takip edilen toplam 287 hastadan ölümle sonuçlanan 31 (%10,8) olgu alınmıştır. Olguların yaş ortalaması 47 (25-68) yıl olup, bunların 27’si (%90) erkekti. Hastalarımızın çoğunun ölüm nedeni fırsatçı enfeksiyonlar, özellikle dissemine tüberkülozdu. Maligniteler arasında lenfoma ve Kaposi sarkomu gibi AIDS’yi tanımlayanlar en sık ölüm nedenleri olarak belirlenmiştir. Sonuç: Ölüme en sık AIDS ile ilişkili fırsatçı enfeksiyon ve AIDS’yi tanımlayan maligniteler gibi “HIV ile ilişkili” nedenler neden olmuştur. HIV/AIDS’nin erken teşhisi için risk gruplarının taranması ve tanı konulan hastaların takip ve tedavide tutulması için daha fazla çaba gösterilmelidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. UNAIDS. Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. https://www.unaids.org/sites/default/files/ media_asset/UNAIDS_FactSheet_en.pdf. [Accessed:: 01.09.2022].
  • 2. Guimarães MDC, Carneiro M, Abreu DMX, França EB. HIV/AIDS Mortality in Brazil, 2000-2015: Are there reasons for concern? Rev Bras Epidemiol 2017;20(Suppl 1):182-90.
  • 3. Lartey M, Asante-Quashie A, Essel A, Kenu E, Ganu V, Neequaye A. Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era. Ghana Med J 2015;49:7-11.
  • 4. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı HIV-AIDS İstatistik [Online] Website: https://hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/hiv-aids/hiv-aids- liste/hiv-aids-istatislik [Accessed: 01/09/2022]. (In Turkish)
  • 5. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City. Ann Intern Med 2006;145:397-406.
  • 6. Palella FJ Jr, Baker RK, Moorman AC, et. al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
  • 7. Novoa AM, de Olalla PG, Clos R, Orcau A, Rodríguez-Sanz M, Caylà JA. Increase in the non-HIV-related deaths among AIDS cases in the HAART era. Curr HIV Res 2008;6:77-81.
  • 8. Bekker LG, Egger M, Wood R. Early antiretroviral therapy mortality in resource-limited settings: what can we do about it? Curr Opin HIV AIDS 2007;2:346-51.
  • 9. Ozdemir B, Yetkin MA, Bastug A, et al. Evaluation of epidemiological, clinical, and laboratory features and mortality of 144 HIV/AIDS cases in Turkey. HIV Clin Trials 2018;19:69-74.
  • 10. Erbay A, Kayaaslan B, Akıncı E, et al. Evaluation of Epidemiological, Clinical and Laboratory Features of HIV/AIDS Cases. Flora 2009;14:36- 42
  • 11. Çerçi P, İnkaya AÇ, Alp Ş, Tümer A, Ünal S. Evaluation of 255 HIV/AIDS cases: Hacettepe cohort, Ankara, Turkey. Mikrobiyol Bul 2016;50:94-103.
  • 12. Oliveira MT, Latorre Mdo R, Greco DB. The impact of late diagnosis on the survival of patients following their first AIDS-related hospitalization in Belo Horizonte, Brazil. AIDS Care 2012;24:635-41.
  • 13. Shahrin L, Leung DT, Matin N, et al. Characteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: Bangladesh. PLoS One 2014;9:e113095.
  • 14. Somi G, Keogh SC, Todd J, et al. Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health 2012;17:497-506.
  • 15. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource- Limited Settings: Systematic Review and Meta-Analysis. PLoS One 2009;4:e5790.
  • 16. Agaba PA, Digin E, Makai R, et al. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J Infect Dev Ctries 2011;5:377-82.
  • 17. Kouanda S, Meda IB, Nikiema L, et al. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 2012;24:478-90.
  • 18. Türk Tabibpleri Birliği. Verem kayıt dışına çıktı. 07.04.2011. Available at: http://www.ttb.org.tr/975yea7.
  • 19. Schneider M, Zwahlen M, Egger M. Natural history and mortality in HIV-positive individuals living in resource-poor settings: A literature review UNAIDS Obligation HQ/03/463871. http://data.unaids.org/pub/ periodical/2004/egger_unaids_hq_03_463871_2007_en.pdf. [Accessed: 21.05.2019].
  • 20. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of Human Immunodeficiency Virus Type 1-Related Opportunistic Infections in Sub-Saharan Africa. Clin Infect Dis 2003;36:652-62.
  • 21. Alp E, Bozkurt I, Doğanay M. Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience. Mikrobiyol Bul 2011;45:125-36.
APA Atalay S, Albayrak Ucak H (2022). Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. , 351 - 356. 10.4274/terh.galenos.2022.53254
Chicago Atalay Sabri,Albayrak Ucak Hazal Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. (2022): 351 - 356. 10.4274/terh.galenos.2022.53254
MLA Atalay Sabri,Albayrak Ucak Hazal Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. , 2022, ss.351 - 356. 10.4274/terh.galenos.2022.53254
AMA Atalay S,Albayrak Ucak H Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. . 2022; 351 - 356. 10.4274/terh.galenos.2022.53254
Vancouver Atalay S,Albayrak Ucak H Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. . 2022; 351 - 356. 10.4274/terh.galenos.2022.53254
IEEE Atalay S,Albayrak Ucak H "Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey." , ss.351 - 356, 2022. 10.4274/terh.galenos.2022.53254
ISNAD Atalay, Sabri - Albayrak Ucak, Hazal. "Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey". (2022), 351-356. https://doi.org/10.4274/terh.galenos.2022.53254
APA Atalay S, Albayrak Ucak H (2022). Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. İzmir Tepecik Eğitim Hastanesi Dergisi, 32(3), 351 - 356. 10.4274/terh.galenos.2022.53254
Chicago Atalay Sabri,Albayrak Ucak Hazal Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. İzmir Tepecik Eğitim Hastanesi Dergisi 32, no.3 (2022): 351 - 356. 10.4274/terh.galenos.2022.53254
MLA Atalay Sabri,Albayrak Ucak Hazal Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. İzmir Tepecik Eğitim Hastanesi Dergisi, vol.32, no.3, 2022, ss.351 - 356. 10.4274/terh.galenos.2022.53254
AMA Atalay S,Albayrak Ucak H Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. İzmir Tepecik Eğitim Hastanesi Dergisi. 2022; 32(3): 351 - 356. 10.4274/terh.galenos.2022.53254
Vancouver Atalay S,Albayrak Ucak H Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey. İzmir Tepecik Eğitim Hastanesi Dergisi. 2022; 32(3): 351 - 356. 10.4274/terh.galenos.2022.53254
IEEE Atalay S,Albayrak Ucak H "Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey." İzmir Tepecik Eğitim Hastanesi Dergisi, 32, ss.351 - 356, 2022. 10.4274/terh.galenos.2022.53254
ISNAD Atalay, Sabri - Albayrak Ucak, Hazal. "Mortality Causes of HIV-positive Patients: Evaluation of 31 Cases in Turkey". İzmir Tepecik Eğitim Hastanesi Dergisi 32/3 (2022), 351-356. https://doi.org/10.4274/terh.galenos.2022.53254